Full Professor of General and Inorganic Chemistry

Adolfo Speghini is Full Professor of General and Inorganic Chemistry at the University of Verona. Since 2019, he has been Coordinator of the Faculty Board of the Doctorate program in "Nanoscience and Advanced Technologies" at the University of Verona. Coordinator of various national and international research projects, he has been a Visiting Scholar or Professor at foreign universities and institutions (University of Pennsylvania, Philadelphia (USA); Concordia University, Montreal, Canada; Universidad Autonoma de Madrid, Spain; Polish Academy of Sciences, Poland; Humboldt-Universitat zu Berlin, Germany; Universidad Autonoma Metropolitana, Mexico City; Université du Québec, INRS-EMT, Canada).
He has organized international conferences ("8th International Conference on f-Elements (ICFE8), Udine, Italy) and was co-chair of the "XXIII International MRS Congress, Symposium 6E. Luminescent Materials," Cancun, Mexico.
He has presented scientific contributions at numerous international conferences, including as an invited or keynote speaker.
He is the author of more than 360 publications in international scientific journals, with a total number of citations exceeding 15,000 and an h-index of 62 (WoS), and holds two patents. He serves as a scientific reviewer for many international journals (ACS, RSC, Elsevier, Wiley) and for national research agencies (MIUR) and international research projects (ERC, National Science Centre, Poland; FCT, Portugal; Canada Foundation for Innovation).
He is a member of the editorial boards of scientific journals in the field of nanotechnology (Journal of Nanoparticle Research, Springer Science, Associate Editor). His recent research focuses on the study of various types of inorganic nanocrystalline materials activated with luminescent lanthanide ions. The focus is on basic spectroscopic aspects and possible technological applications. Recently, his research has been
directed towards the development of multifunctional inorganic nanomaterials for nanomedicine.